1,841
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Hypothetical assessment of efficiency, willingness-to-accept and willingness-to-pay for dengue vaccine and treatment: a contingent valuation survey in Bangladesh

ORCID Icon, ORCID Icon & ORCID Icon
Pages 773-784 | Received 26 Apr 2020, Accepted 12 Jul 2020, Published online: 21 Aug 2020

Figures & data

Figure 1. (A) Combined bar and line graph to show the number of reported dengue cases from 2000–2019 (blue color bar chart presents dengue cases and red color line graph shows death cases). The dengue cases (blue) with death (red) for 2019 (January1st–September 9th) is represented by an inset diagram. (B) Map of Bangladesh indicating dengue-affected people in 64 districts from January 1st–September 9th, 2019 (health emergency operation center and control room, DGHS, Bangladesh) and survey locations (black-filled circle)

Figure 1. (A) Combined bar and line graph to show the number of reported dengue cases from 2000–2019 (blue color bar chart presents dengue cases and red color line graph shows death cases). The dengue cases (blue) with death (red) for 2019 (January1st–September 9th) is represented by an inset diagram. (B) Map of Bangladesh indicating dengue-affected people in 64 districts from January 1st–September 9th, 2019 (health emergency operation center and control room, DGHS, Bangladesh) and survey locations (black-filled circle)

Figure 2. Double-bounded dichotomous choice and bidding game approach presented for elicitation of WTP amount. Since there was no previous data about the cost of the dengue vaccine available in Bangladesh, the starting bid (A-US$ 35, B-US$ 60, C-US$ 70, and T-US$ 95) was established by referring to some previous studies and tests online. Here, No indicates an unwillingness to pay and Yes indicates WTP

Figure 2. Double-bounded dichotomous choice and bidding game approach presented for elicitation of WTP amount. Since there was no previous data about the cost of the dengue vaccine available in Bangladesh, the starting bid (A-US$ 35, B-US$ 60, C-US$ 70, and T-US$ 95) was established by referring to some previous studies and tests online. Here, No indicates an unwillingness to pay and Yes indicates WTP

Table 1. Respondents’ socio-demographic profile of dengue vaccine acceptance (n=3251)

Table 2. Respondents’ socio-demographic profile of dengue vaccine acceptance (n=3251)

Figure 3. The percentage share of (A) dengue knowledge and (B) dengue prevention practices categorized by the respondents’ socio-demographic characteristics

Figure 3. The percentage share of (A) dengue knowledge and (B) dengue prevention practices categorized by the respondents’ socio-demographic characteristics

Figure 4. Statistics of WTP of respondents, classified by socio-demographic characteristics: (A) Gender, (B) age, (C) area, (D) marital status, (E) education, (F) occupation, (G) income, and (H) dengue experience. Values with *, **, and *** refer to statistical significance with a level 5%, 1%, and 0.1%, respectively

Figure 4. Statistics of WTP of respondents, classified by socio-demographic characteristics: (A) Gender, (B) age, (C) area, (D) marital status, (E) education, (F) occupation, (G) income, and (H) dengue experience. Values with *, **, and *** refer to statistical significance with a level 5%, 1%, and 0.1%, respectively

Figure 5. Bar chart of mean WTP for respondents’ groups categorized according to two attributes; (A) vaccine A for occupation vs. area, (B) vaccine A for income vs. area, (C) vaccine B for occupation vs. area, (D) vaccine B for age vs. experience, (E) vaccine C for occupation vs. area and (F) vaccine C for

Figure 5. Bar chart of mean WTP for respondents’ groups categorized according to two attributes; (A) vaccine A for occupation vs. area, (B) vaccine A for income vs. area, (C) vaccine B for occupation vs. area, (D) vaccine B for age vs. experience, (E) vaccine C for occupation vs. area and (F) vaccine C for

Table 3. ANOVA analysis (p-value) of multiple factors of respondents’ socio-demographic conditions on willingness to pay for vaccines A, B, and C. Values with *, **, and *** refer to statistical significance with a level 5%, 1%, and 0.1%, respectively. Green, blue, and white colors mean that both factors were significant, only one factor was significant, and none were significant, respectively

Figure 6. (A) Statistical summaries of respondents’ mean WTP, WTA for vaccines A, B, and C, and treatment T. (B) Histogram of respondents’ WTP for hypothetical vaccinations indicating willingness to accept the vaccine

Figure 6. (A) Statistical summaries of respondents’ mean WTP, WTA for vaccines A, B, and C, and treatment T. (B) Histogram of respondents’ WTP for hypothetical vaccinations indicating willingness to accept the vaccine

Figure 7. 2D phase diagram of vaccination coverage/willingness to accept (WTP); (A) survey results (B) epidemic vaccination game model with repeated seasonsCitation43 and (C) single-season epidemic model.Citation45

Figure 7. 2D phase diagram of vaccination coverage/willingness to accept (WTP); (A) survey results (B) epidemic vaccination game model with repeated seasonsCitation43 and (C) single-season epidemic model.Citation45
Supplemental material

Supplemental Material

Download MS Word (2.6 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.